Global Electrophysiology Ablation Catheters Medical Device Pipeline Market Landscape Report 2021: Product Description, Licensing and Collaboration Details & Developmental Activities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Electrophysiology Ablation Catheters - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

"Electrophysiology Ablation Catheters - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Electrophysiology Ablation Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

An electrophysiology ablation catheter contains an electrode on one end which emits RF waves to destroy a small area of heart tissue in the abnormal conduction pathway, blocking further channeling of the impulses causing the heart's abnormal rhythm.

Scope

• Extensive coverage of the Electrophysiology Ablation Catheters under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Electrophysiology Ablation Catheters and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Electrophysiology Ablation Catheters under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Electrophysiology Ablation Catheters Overview

3 Products under Development

3.1 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development

3.2 Electrophysiology Ablation Catheters - Pipeline Products by Segment

3.3 Electrophysiology Ablation Catheters - Pipeline Products by Territory

3.4 Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path

3.5 Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date

3.6 Electrophysiology Ablation Catheters - Ongoing Clinical Trials

4 Electrophysiology Ablation Catheters - Pipeline Products under Development by Companies

4.1 Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development

4.2 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development

5 Electrophysiology Ablation Catheters Companies and Product Overview

5.1 Ablacon Inc Company Overview

5.2 Acotec Scientific Co Ltd Company Overview

5.3 Apama Medical Inc Company Overview

5.4 Biosense Webster Inc Company Overview

5.5 BioTex Inc Company Overview

5.6 Boston Scientific Corp Company Overview

5.7 CardioFocus Inc Company Overview

5.8 CardioNova Ltd Company Overview

5.9 CathEffects LLC Company Overview

5.10 CathRx Ltd Company Overview

5.11 Cibiem Inc Company Overview

5.12 Columbia University Company Overview

5.13 Cordis Corp Company Overview

5.14 CoreMap Inc Company Overview

5.15 CPSI Biotech Company Overview

5.16 CryoTherapeutics Gmbh Company Overview

5.17 Epicardial Technologies Inc (Inactive) Company Overview

5.18 Ethicon US LLC Company Overview

5.19 Eximo Medical Ltd Company Overview

5.20 FocusStart LLC Company Overview

5.21 Hansen Medical Inc (Inactive) Company Overview

5.22 Hyblate Medical Company Overview

5.23 Imricor Medical Systems Inc Company Overview

5.24 Interventional Imaging, Inc. Company Overview

5.25 Iowa Approach Inc. Company Overview

5.26 Maestro Heart SA Company Overview

5.27 Medlumics SL Company Overview

5.28 Medtronic Plc Company Overview

5.29 MedWaves Inc Company Overview

5.30 MicroPort Scientific Corp Company Overview

5.31 Northwestern University Company Overview

5.32 Novasentis Inc Company Overview

5.33 S4 Medical Corp Company Overview

5.34 SCR, Inc. Company Overview

5.35 Seattle Children's Hospital Company Overview

5.36 Shanghai HeartCare Medical Technology Co Ltd Company Overview

5.37 Shanghai MicroPort EP MedTech Co Ltd Company Overview

5.38 St. Jude Medical LLC Company Overview

5.39 Stereotaxis Inc Company Overview

5.40 University of Arkansas at Little Rock Company Overview

5.41 University of Michigan Company Overview

5.42 University of Rochester Company Overview

5.43 University of Texas Medical Branch at Galveston Company Overview

5.44 Vanderbilt University Company Overview

5.45 Vimecon GmbH Company Overview

5.46 Vivonics Inc Company Overview

5.47 Voyage Medical (Inactive) Company Overview

5.48 Zylox-Tonbridge Medical Technology Co Ltd Company Overview

6 Electrophysiology Ablation Catheters- Recent Developments

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/3dued3

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900